AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Synaptic Pharmaceutical Corp has been awarded a US patent (6,156,518) for the use of the alpha adrenergic 1B and 1D receptors to screen compounds that bind to them.
The alpha adrenergic patent estate now includes the screening claims for the 1A, 1B and 1D receptors.
Synaptic Pharmaceutical Corp is a drug discovery …